Terms: = Colorectal cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Treatment
54 results:
1. Factors associated with sexual dysfunction in patients with colorectal cancer in Iran: a cross-sectional study.
Dahouri A; Sahebihagh MH; Gilani N
Sci Rep; 2024 Feb; 14(1):4915. PubMed ID: 38418573
[TBL] [Abstract] [Full Text] [Related]
2. MiR-26a-5p exerts its influence by targeting ep300, a molecule known for its role in activating the PI3K/AKT/mTOR signaling pathway in CD8+tumor-infiltrating lymphocytes of colorectal cancer.
Wang C; Lin H; Zhao W; Liang Y; Chen Y; Wang C
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(12):232-241. PubMed ID: 38063089
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptome and proteome analysis reveals the anti-cancer properties of Hypnea musciformis marine macroalga extract in liver and intestinal cancer cells.
Begolli R; Chatziangelou M; Samiotaki M; Goutas A; Barda S; Goutzourelas N; Kevrekidis DP; Malea P; Trachana V; Liu M; Lin X; Kollatos N; Stagos D; Giakountis A
Hum Genomics; 2023 Jul; 17(1):71. PubMed ID: 37525271
[TBL] [Abstract] [Full Text] [Related]
4. Glutamate dehydrogenase1 supports HIF-1α stability to promote colorectal tumorigenesis under hypoxia.
Hu K; Ding Y; Zhu H; Jing X; He W; Yu H; Wang X
EMBO J; 2023 Jun; 42(12):e112675. PubMed ID: 37092319
[TBL] [Abstract] [Full Text] [Related]
5. CXCL1 promotes colon cancer progression through activation of NF-κB/p300 signaling pathway.
Zhuo C; Ruan Q; Zhao X; Shen Y; Lin R
Biol Direct; 2022 Nov; 17(1):34. PubMed ID: 36434686
[TBL] [Abstract] [Full Text] [Related]
6. A genetic map of the chromatin regulators to drug response in cancer cells.
Chen B; Li P; Liu M; Liu K; Zou M; Geng Y; Zhuang S; Xu H; Wang L; Chen T; Li Y; Zhao Z; Qi L; Gu Y
J Transl Med; 2022 Sep; 20(1):438. PubMed ID: 36180906
[TBL] [Abstract] [Full Text] [Related]
7. Sirtuin1 (SIRT1) is involved in the anticancer effect of black raspberry anthocyanins in colorectal cancer.
Chen L; Li M; Zhou H; Liu Y; Pang W; Ma T; Niu C; Yang Z; Chang AK; Li X; Bi X
Eur J Nutr; 2023 Feb; 62(1):395-406. PubMed ID: 36056948
[TBL] [Abstract] [Full Text] [Related]
8. Pre-treatment Staging Imaging in Rectal cancer: Results From the Quality Oncology Practice Initiative.
Chen RC; Garrett-Mayer E; Kamal AH; Makhoul I; Kozlik MMP; Crist STS; Chiang AC;
JCO Oncol Pract; 2022 Aug; 18(8):e1367-e1373. PubMed ID: 35353546
[TBL] [Abstract] [Full Text] [Related]
9. ERα promotes transcription of tumor suppressor gene
Wang B; Shen Y; Liu T; Tan L
J Zhejiang Univ Sci B; 2021 Dec; 22(12):1034-1044. PubMed ID: 34904415
[TBL] [Abstract] [Full Text] [Related]
10. Identification of Two Novel CIL-102 Upregulations of ERP29 and FUMH to Inhibit the Migration and Invasiveness of colorectal cancer Cells by Using the Proteomic Approach.
Cheng KC; Kuo HC; Hsieh MC; Huang CY; Teng CC; Tung SY; Shen CH; Lee KF; Yang YL; Lee KC
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572494
[TBL] [Abstract] [Full Text] [Related]
11. Ajuba transactivates N-cadherin expression in colorectal cancer cells through interaction with Twist.
Wu Z; Zou X; Xu Y; Zhou F; Kuai R; Li J; Yang D; Chu Y; Peng H
J Cell Mol Med; 2021 Aug; 25(16):8006-8014. PubMed ID: 34173718
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic regulation of intestinal peptide transporter PEPT1 as a potential strategy for colorectal cancer sensitization.
Wang Y; Wang J; Yang L; Qiu L; Hua Y; Wu S; Zeng S; Yu L; Zheng X
Cell Death Dis; 2021 May; 12(6):532. PubMed ID: 34031358
[TBL] [Abstract] [Full Text] [Related]
13. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.
Chen SJ; Chen LH; Yeh YM; Lin CK; Lin PC; Huang HW; Shen MR; Lin BW; Lee JC; Lee CC; Lee YF; Chiang HC; Chang JY
Theranostics; 2021; 11(10):4672-4687. PubMed ID: 33754020
[No Abstract] [Full Text] [Related]
14. Novel regulator role of CIL-102 in the epigenetic modification of TNFR1/TRAIL to induce cell apoptosis in human gastric cancer.
Teng CC; Tung SY; Lee KC; Lee KF; Huang WS; Shen CH; Hsieh MC; Huang CY; Sheen JM; Kuo HC
Food Chem Toxicol; 2021 Jan; 147():111856. PubMed ID: 33246054
[TBL] [Abstract] [Full Text] [Related]
15. Characterization of genomic alterations in Chinese colorectal cancer patients.
Huang W; Li H; Shi X; Lin M; Liao C; Zhang S; Shi W; Zhang L; Zhang X; Gan J
Jpn J Clin Oncol; 2021 Jan; 51(1):120-129. PubMed ID: 33106877
[TBL] [Abstract] [Full Text] [Related]
16. Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study.
Liang Y; Zhou R; Liang X; Kong X; Yang B
Eur J Pharmacol; 2020 Aug; 881():173227. PubMed ID: 32505664
[TBL] [Abstract] [Full Text] [Related]
17. Histone Acetyltransferase (HAT) p300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient colorectal cancer Cells through Destabilizing AKT.
Liu Y; Yang EJ; Shi C; Mou PK; Zhang B; Wu C; Lyu J; Shim JS
Int J Biol Sci; 2020; 16(11):1774-1784. PubMed ID: 32398948
[TBL] [Abstract] [Full Text] [Related]
18. A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL.
Zhang B; Chen D; Liu B; Dekker FJ; Quax WJ
Biochem Pharmacol; 2020 May; 175():113914. PubMed ID: 32173363
[TBL] [Abstract] [Full Text] [Related]
19. A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood cancer Survivors.
Biller LH; Ukaegbu C; Dhingra TG; Burke CA; Chertock Y; Chittenden A; Church JM; Koeppe ES; Leach BH; Levinson E; Lim RM; Lutz M; Salo-Mullen E; Sheikh R; Idos G; Kastrinos F; Stoffel E; Weiss JM; Hall MJ; Kalady MF; Stadler ZK; Syngal S; Yurgelun MB
Cancer Prev Res (Phila); 2020 Mar; 13(3):291-298. PubMed ID: 32051178
[TBL] [Abstract] [Full Text] [Related]
20. Epigenetic Mechanisms Underlying Organic Solute Transporter
Zhou Y; Ye C; Lou Y; Liu J; Ye S; Chen L; Lei J; Guo S; Zeng S; Yu L
Mol Pharmacol; 2020 Apr; 97(4):259-266. PubMed ID: 32005758
[TBL] [Abstract] [Full Text] [Related]
[Next]
